13 Aug 2021 --- The need for better regulation around hemp-derived products has been flagged following the US Food and Drug Administration (FDA)’s rejection of two new dietary ingredient (NDI) notifications for full-spectrum hemp extract (FSHE) containing CBD. “We tested the water to get the FDA’s reaction. Now Congress must provide a framework under which the FDA can regulate the category,” Kelly Shea, senior vice president of government affairs at Charlotte’s Web, tells NutritionInsight.
